Shanghai HOB Biological Medicine

Shanghai HOB Biological Medicine Co., Ltd. is a wholly-owned subsidiary of HOB Biotech Group Corp., Ltd. (Jiangsu HOB), a leading Chinese in vitro diagnostics (IVD) company specializing in allergy and autoimmune disease testing. Shanghai HOB focuses on expanding the parent company's business into the therapeutic space, specifically allergen immunotherapy (AIT). Through an exclusive strategic partnership with Spanish biopharmaceutical company Inmunotek S.L., Shanghai HOB is developing and commercializing the Oraltek (欧脱克) series of desensitization drugs in China. Its lead clinical program, MM09, is a sublingual spray containing purified house dust mite allergen extracts currently in Phase III clinical trials for the treatment of allergic rhinitis, allergic rhinoconjunctivitis, and allergic asthma.